(E)-4-(4-(2-((TERT-BUTOXYCARBONYL)AMINO)ETHYL)PIPERAZIN-1-YL)BUT-2-ENOIC ACID, 97%, 5g

2-CHLORO-5-NITRO-3-(TRIFLUOROMETHYL)PYRIDINE, 95.0%, 100g

4-Methyl-2,3-dihydrocyclopenta[b]indol-1(4H)-one, 98%, 1g

3,4-dihydropyrimidin-4-one, 95%, 1g

5,5,8,8-Tetramethyl-2,3,5,6,7,8-hexahydro-1H-cyclopenta[b]naphthalen-1-one, 97.0%, 250mg

4-Piperidinecarboxylic acid t-butyl ester hydrochloride, 95.0%, 1g

4-(chloromethyl)-2-(3-methylphenyl)-1,3-thiazole, 95.0%, 5g

7-Diethylamino-4-methylcoumarin>98.0%(GC)(T)25g

1,3-DIBROMO-2,2-DIMETHYLPROPANE, 95.0%, 5g

2,5-Dibromo-4-methylimidazole, 95.0%, 5g

4-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)morpholine, 95.0%, 1g

tert-Butyl [4,4'-bipiperidine]-1-carboxylate, 95.0%, 250mg

Ethyl 1-acetylcyclopropanecarboxylate, 95.0%, 100g